Literature DB >> 15887287

The transactivating isoforms of p63 are overexpressed in high-grade follicular lymphomas independent of the occurrence of p63 gene amplification.

Giancarlo Pruneri1, Sonia Fabris, Patrizia Dell'Orto, Maria Olivia Biasi, Stefano Valentini, Barbara Del Curto, Daniele Laszlo, Laura Cattaneo, Roberta Fasani, Laura Rossini, Michela Manzotti, Francesco Bertolini, Giovanni Martinelli, Antonino Neri, Giuseppe Viale.   

Abstract

p63 is a p53-related gene mapping to 3q28 that codes for multiple mRNA transcripts with (TA-p63) or without (DeltaN-p63) transactivating effects on genes that promote cell differentiation and apoptosis. We analysed p63 alterations by immunohistochemistry, quantitative real-time RT-PCR and FISH in a series of 45 follicular lymphomas (FL). None of the tumours showed immunoreactivity for the p40 antibody, which recognizes only the truncated isoforms of p63, or DeltaN-p63 mRNA expression. Immunoreactivity for the 4A4 antibody, which recognizes both the transactivating and the truncated p63 isoforms, was found in 5 +/- 5.5%, 6.85 +/- 4.88% and 33.2 +/- 22.31% of grade I, II and III FL cells, respectively (p < 0.0001). Quantitative RT-PCR analysis showed that all cases but one had TA-p63 mRNA levels higher than non-neoplastic lymphocytes, and that TA-p63 mRNA expression correlated significantly (r = 0.9194, p < 0.0001) with the prevalence of p63 immunoreactivity. FISH extra signals for the p63 gene were found in seven (23.3%) of the 30 cases analysed (0/6 grade I, 2/15 grade II and 5/9 grade III; p = 0.01937). Further hybridizations showed a pattern highly suggestive of chromosome 3 polysomy in six cases. One of these cases also bore extra copies of the p63 and bcl-6 genes. Co-localization of p63 and IgH signals was found in one case. No association between the prevalence of p63 immunoreactivity and extra p63 gene signals was detectable when the cases were dichotomized according to a p63 immunoreactivity threshold of 10%. Our data suggest that TA-p63 is overexpressed in high-grade FL, possibly independent of the occurrence of gene abnormalities, and that it may be involved in the highly complex mechanism of regulation of apoptosis of FL cells. Copyright 2005 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15887287     DOI: 10.1002/path.1787

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  18 in total

1.  Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping.

Authors:  Xueju Wang; Rebecca L Boddicker; Surendra Dasari; Jagmohan S Sidhu; Marshall E Kadin; William R Macon; Stephen M Ansell; Rhett P Ketterling; Karen L Rech; Andrew L Feldman
Journal:  Hum Pathol       Date:  2017-01-30       Impact factor: 3.466

2.  A rare association of B cell lymphoma and ectodermal dysplasia presenting with protein-losing enteropathy.

Authors:  Mohamed Yousha Yousuf; Faraz Imran; Andrew Davis
Journal:  BMJ Case Rep       Date:  2009-02-27

3.  Overexpression and ratio disruption of ΔNp63 and TAp63 isoform equilibrium in endometrial adenocarcinoma: correlation with obesity, menopause, and grade I/II tumors.

Authors:  Eleni Vakonaki; Nikolaos Soulitzis; Stavros Sifakis; Danae Papadogianni; Dimitrios Koutroulakis; Demetrios A Spandidos
Journal:  J Cancer Res Clin Oncol       Date:  2012-03-24       Impact factor: 4.553

4.  Characterization of specific p63 and p63-N-terminal isoform antibodies and their application for immunohistochemistry.

Authors:  Marta Nekulova; Jitka Holcakova; Rudolf Nenutil; Rembert Stratmann; Pavla Bouchalova; Petr Müller; Lucie Mouková; Philip J Coates; Borivoj Vojtesek
Journal:  Virchows Arch       Date:  2013-07-26       Impact factor: 4.064

5.  p63 heterozygous mutant mice are not prone to spontaneous or chemically induced tumors.

Authors:  William M Keyes; Hannes Vogel; Maranke I Koster; Xuecui Guo; Yi Qi; Kristin M Petherbridge; Dennis R Roop; Allan Bradley; Alea A Mills
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-19       Impact factor: 11.205

6.  Apoptosis induced by genipin in human leukemia K562 cells: involvement of c-Jun N-terminal kinase in G₂/M arrest.

Authors:  Qian Feng; Hou-li Cao; Wei Xu; Xiao-rong Li; Yan-qin Ren; Lin-fang Du
Journal:  Acta Pharmacol Sin       Date:  2011-03-14       Impact factor: 6.150

7.  Role of p63 in Development, Tumorigenesis and Cancer Progression.

Authors:  Johann Bergholz; Zhi-Xiong Xiao
Journal:  Cancer Microenviron       Date:  2012-07-31

8.  NIR, an inhibitor of histone acetyltransferases, regulates transcription factor TAp63 and is controlled by the cell cycle.

Authors:  Kristina Heyne; Vivienne Willnecker; Julia Schneider; Marcel Conrad; Nina Raulf; Roland Schüle; Klaus Roemer
Journal:  Nucleic Acids Res       Date:  2010-01-31       Impact factor: 16.971

9.  p63 isoforms in triple-negative breast cancer: ΔNp63 associates with the basal phenotype whereas TAp63 associates with androgen receptor, lack of BRCA mutation, PTEN and improved survival.

Authors:  Philip J Coates; Rudolf Nenutil; Jitka Holcakova; Marta Nekulova; Jan Podhorec; Marek Svoboda; Borivoj Vojtesek
Journal:  Virchows Arch       Date:  2018-02-27       Impact factor: 4.064

Review 10.  A double dealing tale of p63: an oncogene or a tumor suppressor.

Authors:  Yonglong Chen; Yougong Peng; Shijie Fan; Yimin Li; Zhi-Xiong Xiao; Chenghua Li
Journal:  Cell Mol Life Sci       Date:  2017-10-03       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.